GB202108677D0 - Therapeutic antibodies - Google Patents
Therapeutic antibodiesInfo
- Publication number
- GB202108677D0 GB202108677D0 GBGB2108677.2A GB202108677A GB202108677D0 GB 202108677 D0 GB202108677 D0 GB 202108677D0 GB 202108677 A GB202108677 A GB 202108677A GB 202108677 D0 GB202108677 D0 GB 202108677D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic antibodies
- antibodies
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2108677.2A GB202108677D0 (en) | 2021-06-17 | 2021-06-17 | Therapeutic antibodies |
KR1020247001684A KR20240021959A (en) | 2021-06-17 | 2022-06-17 | Anti-canine CD20 antibody |
JP2023577850A JP2024526122A (en) | 2021-06-17 | 2022-06-17 | Anti-canine CD20 antibody |
CA3224517A CA3224517A1 (en) | 2021-06-17 | 2022-06-17 | Anti canine cd20 antibodies |
BR112023026592A BR112023026592A2 (en) | 2021-06-17 | 2022-06-17 | ANTI-CANINE CD20 ANTIBODIES |
PCT/GB2022/051559 WO2022263864A1 (en) | 2021-06-17 | 2022-06-17 | Anti canine cd20 antibodies |
EP22740459.7A EP4355782A1 (en) | 2021-06-17 | 2022-06-17 | Anti canine cd20 antibodies |
AU2022294198A AU2022294198A1 (en) | 2021-06-17 | 2022-06-17 | Anti canine cd20 antibodies |
MX2023015152A MX2023015152A (en) | 2021-06-17 | 2022-06-17 | Anti canine cd20 antibodies. |
CONC2024/0000339A CO2024000339A2 (en) | 2021-06-17 | 2024-01-16 | Canine anti-cd20 antibodies |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2108677.2A GB202108677D0 (en) | 2021-06-17 | 2021-06-17 | Therapeutic antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202108677D0 true GB202108677D0 (en) | 2021-08-04 |
Family
ID=77050615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2108677.2A Ceased GB202108677D0 (en) | 2021-06-17 | 2021-06-17 | Therapeutic antibodies |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202108677D0 (en) |
-
2021
- 2021-06-17 GB GBGB2108677.2A patent/GB202108677D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3880239A4 (en) | THERAPEUTIC SIRPalpha ANTIBODIES | |
GB202012331D0 (en) | Therapeutic antibodies | |
IL291486A (en) | Therapeutic conjugates | |
IL308741A (en) | Anti-sirp-alpha antibodies | |
IL285134A (en) | Therapeutic antibody formulation | |
GB202001980D0 (en) | Therapeutic mentods | |
IL304200A (en) | Combination therapy using an anti-fucosyl-gm1 antibody | |
GB202006960D0 (en) | Therapeutic | |
IL311043A (en) | Anti-il-11rα antibodies | |
IL300142A (en) | ANTI-IL13Ralpha2 ANTIBODIES | |
GB202105110D0 (en) | Anti-CD73 antibodies | |
GB202014851D0 (en) | SARS-COV-2 antibodies | |
GB202108677D0 (en) | Therapeutic antibodies | |
GB202311497D0 (en) | Therapeutic antibodies | |
GB202310818D0 (en) | Therapeutic antibodies | |
IL314314A (en) | Therapeutic antibodies | |
GB202300904D0 (en) | Therapeutic antibodies | |
GB202217993D0 (en) | Therapeutic antibodies | |
GB202209454D0 (en) | Therapeutic antibodies | |
GB202208544D0 (en) | Therapeutic antibodies | |
GB202202990D0 (en) | Therapeutic antibodies | |
GB202202635D0 (en) | Therapeutic antibodies | |
IL292599A (en) | Tmem219 antibodies and therapeutic uses thereof | |
IL310245A (en) | Anti-hla-g antibodies | |
GB202208773D0 (en) | Anti-SARS2-S antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |